Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions

ESMO 2017 Congress

Visit Q2 Solutions at Booth #216

Madrid, Spain | September 08, 2017 - September 12, 2017 | 08:00 - 17:00 Add to Calendar
Stay Informed Schedule a Meeting

About This Event

The ESMO 2017 Congress, in partnership with the European Association for Cancer Research (EACR), will bring cancer researchers and clinicians together to enable collaboration and the exchange of ideas, from the laboratory to the bedside and back.

Schedule a meeting with our experts at booth #216 (QuintilesIMS booth) to discover how Q2 Solutions' end-to-end laboratory services can optimize your oncology clinical development program. 

We look forward to meeting you in Madrid!

Register for Event

Minimal Residual Disease: Finding the Right Test for the New Definition of Remission

Measurement of Residual Disease for improved oncology trial outcomes

Genomic Based Solutions for Your Immuno-oncology Drug Development Needs

Genomics-based biomarker approach

New Opportunities for Immuno-oncology Clinical Development Programs through T cell/B cell Repertoire Profiling

Immune repertoire profiling provides better outcomes for immuno-oncology development programs

Clinical Trials Laboratories in the Immuno-Oncology Setting

Increased demands lead to increased opportunities

Q2 Solutions Oncology Infographic

Providing one global lab partner to support your oncology research from discovery to post-market

Read More